Clearstead Advisors’s Protagonist Therapeutics PTGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$6.08K Hold
110
﹤0.01% 2048
2025
Q1
$5.32K Hold
110
﹤0.01% 1732
2024
Q4
$4.25K Hold
110
﹤0.01% 1741
2024
Q3
$4.95K Hold
110
﹤0.01% 1709
2024
Q2
$3.81K Buy
+110
New +$3.81K ﹤0.01% 1727